Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common renal malignancy, although newly developing targeted therapy and immunotherapy have been showing promising effects in clinical treatment, the effective biomarkers for immune response prediction are still lacking. The study is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Ziwei, Du, Juan, Wu, Nan, Shen, Ningning, Yang, Zhiqing, Yang, Huijun, Wang, Xuzhi, Zhao, Na, Zeng, Zixin, Wei, Rong, Ma, Wenxia, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337188/
https://www.ncbi.nlm.nih.gov/pubmed/37438709
http://dx.doi.org/10.1186/s12885-023-11150-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337188/
https://www.ncbi.nlm.nih.gov/pubmed/37438709
http://dx.doi.org/10.1186/s12885-023-11150-4

Ejemplares similares